Brought to you by 
GSK buys some AstraZeneca OTC products for $253mm
15 Mar 2012
Executive Summary
AstraZeneca has sold a group of its OTC drugs to GlaxoSmithKline Consumer Healthcare for $253mm in cash, getting more than five times what the portfolio achieved in 2007 sales. AZ's AZ Tika division currently markets these products.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- OTC, Consumer
Deal Status
- Final
Deal Type
-
Alliance
- Product Purchase
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com